Commerzbank set a €67.00 ($77.91) price target on Symrise (FRA:SY1) in a research note published on Wednesday. The firm currently has a neutral rating on the stock.

A number of other equities research analysts have also weighed in on the company. Morgan Stanley set a €75.00 ($87.21) target price on Symrise and gave the company a neutral rating in a research report on Wednesday, August 29th. Societe Generale set a €91.00 ($105.81) target price on Symrise and gave the company a buy rating in a research report on Monday, August 27th. Goldman Sachs Group set a €58.20 ($67.67) target price on Symrise and gave the company a sell rating in a research report on Monday, September 3rd. Hauck & Aufhaeuser set a €75.00 ($87.21) target price on Symrise and gave the company a neutral rating in a research report on Friday, August 31st. Finally, UBS Group set a €82.00 ($95.35) target price on Symrise and gave the company a neutral rating in a research report on Tuesday, September 25th. Three analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have given a buy rating to the company. The stock has an average rating of Hold and an average target price of €74.09 ($86.15).

SY1 opened at €72.02 ($83.74) on Wednesday. Symrise has a 52-week low of €56.96 ($66.23) and a 52-week high of €73.48 ($85.44).

About Symrise

Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.

Featured Article: How are Outstanding Shares Different from Authorized Shares?

Analyst Recommendations for Symrise (FRA:SY1)

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.